The Scientific Advisory Committee welcomes the submission of Late Breaking Abstracts for presentation at the APSAD Auckland 2018 Conference. We are calling for abstracts for the following presentation types;
|Presentation Type||Time allocated||Description|
|Oral Presentation||5 minutes (maximum of 5 slides)||Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.|
|Poster Presentation||Permanently displayed during the conference.
Authors must be standing with their posters during the dedicated Poster Session
|Posters can present research in progress, case studies, divisional projects or clinical topics. A poster viewing session will take place for delegates to discuss the posters with their authors.|
The session is dedicated to late-breaking and unpublished findings and cannot be a revision of an abstract submitted during the general abstract submission process. Late Breaking abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted until Sunday 12 August 2018. For information regarding types of presentations and abstract preparation guidelines please see the abstract guidelines.
Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.
Abstracts must be submitted by Sunday 12 August 2018, there will be no extension to the submission closing date.
The Late Breaking Sessions are lively, informative and fast paced and are held as a single stream, which is a great opportunity to present to all the conference delegates. Presentations are five minutes and should have no more than five slides. This session is one of the most popular sessions at the conference.
Abstracts must be submitted using the appropriate abstract template, please see the template options below;
Please read the abstract guidelines carefully. Any abstracts that do not conform to the guidelines will not be considered.
The Scientific Advisory Committee may reallocate a presentation type on the basis of time, content, space available and applicability to the Conference themes.
Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.
APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.
For an example of a disclosure of interest/ethical statement please see below
Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study.
Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.
Abstracts will be favoured at review if they incorporate:
In balancing the program, the committee may require authors to present their work in an alternate format (e.g. as a poster rather than oral presentation).
Note: We encourage abstracts that are based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the Indigenous community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.
Authors must select one primary and one secondary theme of the following that their abstract relates to.
|Addiction reconceptualised||Adolescents / youth||Other AOD issues|
|Aetiology (including genetics)||Alcohol||Overdose|
|Blood-borne viruses (incl. STI)||Cannabis||Over the counter codeine rescheduling|
|Children & families||Coercive treatment||Pharmaceuticals (consumption)|
|Cognitive impairment training||Comorbidity||Prescription opioid treatment|
|Consumers & peers||Crime, justice & legal issues||Prevention & early intervention|
|Cross culture & international||Drug monitoring/novel psychoactive -||Prisons & prisoner health|
|Drug policy reform||Ecstasy & emerging psychoactive substances||Primary Care - pharmacy in primary care|
|eHealth – behavioural change||Epidemiology||Psychopharmacology & psychobiology|
|First Peoples||Gambling||Regional challenges & innovations|
|Harms & harm reduction||Health policy & reforms||Special populations|
|Health services & systems||Health, law & human rights||Social & community issues|
|Heroin & opioids||Injecting drug use||Translational research|
|Innovative prescribing – medicinal cannabis, e-cigs, etc.||LGBTIQ||Tobacco & Tobacco Cessation|
|Methamphetamine & psychostimulants||Neuroscience||Treatment & interventions|
|Methamphetamine & psychostimulants||Older adults||Treatment settings|
|Workforce issues||Well at Work||Women & maternal issues|
Notifications of acceptance will be sent via e-mail to the submitting author by Wednesday 12 September 2018. Abstracts submitted for oral will also be considered and reviewed for a poster presentation.
The goal of the APSAD Conference Abstract Mentor Program is to provide an opportunity for First Peoples (Aboriginal, Torres Strait Islander and Māori), Community Groups, Consumers and Early Career Researchers to have their draft abstracts mentored by more experienced authors before submitting their abstract to the conference.
Abstracts submitted by authors that have volunteered to be a mentor in the program will not automatically be accepted. The same applies for abstracts submitted by authors that were mentored by the program.
For more information please check the abstract mentor program section.